Thermo Fisher (TMO) Stock Looks Fully Valued Following Its Microbiology Sale

Thermo Fisher Scientific stock has delivered a strong 26.3% return over the past year, yet the valuation checks suggest the shares are no longer an obvious bargain. The Discounted Cash Flow (DCF) estimate points to a level that is close to the current price, while market multiples lean richer. Over the past 12 months Thermo Fisher Scientific has returned 26.3%, which puts more pressure on today’s buyers to justify paying up at current levels. Participation in areas such as protein design...